摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-amino-2-pentylsulfanyl-3H-pyrimidin-4-one

中文名称
——
中文别名
——
英文名称
6-amino-2-pentylsulfanyl-3H-pyrimidin-4-one
英文别名
4-amino-2-pentylsulfanyl-1H-pyrimidin-6-one
6-amino-2-pentylsulfanyl-3H-pyrimidin-4-one化学式
CAS
——
化学式
C9H15N3OS
mdl
——
分子量
213.304
InChiKey
ZTGOICKKTYHRSD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    14
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    92.8
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    6-amino-2-pentylsulfanyl-3H-pyrimidin-4-one吡啶三氯氧磷 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 12.0h, 生成 7-N,7-N-diethyl-5-pentylsulfanyl-[1,3]thiazolo[4,5-d]pyrimidine-2,7-diamine
    参考文献:
    名称:
    Hit-to-Lead studies: The discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists
    摘要:
    A Hit-to-Lead optimisation programme was carried out on a high throughput screening hit, the thiazolopyrimidine 1, resulting in the discovery of the potent, orally bioavailable CXCR2 antagonist 29. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.10.091
  • 作为产物:
    描述:
    6-氨基-2-硫脲嘧啶 、 alkaline earth salt of/the/ methylsulfuric acid 在 sodium hydroxide 作用下, 以 甲醇 为溶剂, 反应 5.0h, 以68%的产率得到6-amino-2-pentylsulfanyl-3H-pyrimidin-4-one
    参考文献:
    名称:
    6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors
    摘要:
    P2Y(12) plays an important role in platelet aggregation, which makes it an interesting target for antithrombotic agents. Compounds that antagonize P2Y(12) include the active metabolites of thienopyridines and molecules that are structurally related to ATP, which is an antagonist of P2Y(12). During the last few years, our group has been working on the development of P2Y(12) receptors antagonists that are based on an extremely simple chemical structure, the 6-amino-2-mercapto-3H-pyrimidin-4-one, variously substituted at the sulfur and oxygen functions. This nucleus represents the simplified combination of two known P2Y(12) antagonists: the active metabolite of the thienopyridines and ATP derivatives. The effects of the synthesized compounds were tested on ADP-induced human platelet aggregation, using light transmission aggregometry. None of the tested compounds induced platelet aggregation, while some of them, at concentration of 10 (4) M, partially inhibited platelet aggregation induced by ADP 10 (6) M. The most potent compound, 6b, antagonized the inhibitory effect of 2-methylthio-ADP on the forskolin-induced accumulation of cyclic-AMP in CHO FlpIN cells expressing recombinant human P2Y(12)-receptors. In addition, none of the tested compounds, including 6b, interfered with ligand binding to P1 receptors. Our results suggest that some of the synthesized compounds are specific antagonists of P2 receptors, and in particular of P2Y(12) and suggest that further development of this structurally new series of compounds as P2Y(12) receptors antagonists is recommended. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.04.061
点击查看最新优质反应信息

文献信息

  • Synthesis and Biological Evaluation of New Imidazole, Pyrimidine, and Purine Derivatives and Analogs as Inhibitors of Xanthine Oxidase
    作者:Giuliana Biagi、Alberto Costantini、Luca Costantino、Irene Giorgi、Oreste Livi、Piergiorgio Pecorari、Marcella Rinaldi、Valerio Scartoni
    DOI:10.1021/jm950876u
    日期:1996.1.1
    imidazole, 2,4,5-trisubstituted pyrimidine, 2-substituted purine, thiazolo[3,2-alpha]purine, [1,3]thiazino[3,2-alpha]purine, thiazolo[2,3-i]purine, [1,3]thiazino-[2,3-i]purine, and 6-substituted pyrazolo[3,4-d]pyrimidine were synthesized and tested as inhibitors of the xanthine oxidase enzyme. Of those, some 4-(acylamino)-5-carbamoylimidazoles and 2-thioalkyl-substituted purines exhibited very good inhibitory
    4,5-二取代咪唑2,4,5-三取代嘧啶,2-取代嘌呤噻唑并[3,2-α]嘌呤,[1,3]噻嗪并[3,2-α]嘌呤噻唑的几种衍生物合成了[2,3-i]嘌呤,[1,3]噻嗪基-[2,3-i]嘌呤和6-取代的吡唑并[3,4-d]嘧啶,并作为黄嘌呤化酶的抑制剂进行了测试。其中,一些4-(酰基基)-5-基甲酰咪唑和2-代烷基取代的嘌呤表现出非常好的抑制活性,比别嘌呤醇的抑制作用至少强500倍。根据抑制剂嘌呤醇结合的已知机理,可将6-正烷基吡唑并[3,4-d]嘧啶的无效归因于烷基链,这可能阻碍与的配位。咪唑生物的有效性,与之相反,4,5-二基-2-(代烷基)-6-羟基嘧啶表示五元环在与酶相互作用中的相对重要性。此外,有角环化的[1,3]噻嗪基[2,3-i]嘌呤具有显着的功效,构成了有趣的一类新抑制剂,并且线性环化衍生物的活性较弱,这使我们能够表征更多恰好面对底物次黄嘌呤的N(1)-C(2)位置的酶的亲脂性区域。
查看更多

同类化合物

(Rp)-2-(叔丁硫基)-1-(二苯基膦基)二茂铁 (1E)-1-{4-[(4-氨基苯基)硫烷基]苯基}乙酮肟 颜料红88 颜料紫36 顺式-1,2-二(乙硫基)-1-丙烯 非班太尔-D6 雷西那得中间体 阿西替尼杂质J 阿西替尼杂质C 阿西替尼杂质4 阿西替尼杂质 阿西替尼 阿拉氟韦 阿扎毒素 阿嗪米特 阔草特 银(I)(6-氨基-2-(甲硫基)-5-亚硝基嘧啶-4-基)酰胺水合物 钾三氟[3-(苯基硫基)丙基]硼酸酯(1-) 邻甲苯基(对甲苯基)硫化物 避虫醇 连翘脂苷B 还原红 41 还原紫3 还原桃红R 达索尼兴 辛硫醚 辛-1,7-二炔-1-基(苯基)硫烷 西嗪草酮 萘,2-[(2,3-二甲基苯基)硫代]- 莫他哌那非 茴香硫醚 苯醌B 苯酰胺,N-(氨基亚氨基甲基)-4-[(2-甲基苯基)硫代]-3-(甲磺酰)-,盐酸盐 苯酰胺,N-(氨基亚氨基甲基)-4-[(2-氯苯基)硫代]-3-(甲磺酰)-,盐酸盐 苯酰胺,N-(氨基亚氨基甲基)-4-[(2,6-二氯苯基)硫代]-3-(甲磺酰)-,盐酸盐 苯酰胺,2-[(2-硝基苯基)硫代]- 苯酚,3-氯-4-[(4-硝基苯基)硫代]- 苯酚,3-(乙硫基)- 苯酚,3,5-二[(苯基硫代)甲基]- 苯胺,4-[5-溴-3-[4-(甲硫基)苯基]-2-噻嗯基]- 苯胺,3-氯-4-[(1-甲基-1H-咪唑-2-基)硫代]- 苯胺,2-[(2-吡啶基甲基)硫代]- 苯硫醚-D10 苯硫胍 苯硫基乙酸 苯硫代磺酸S-(三氯乙烯基)酯 苯甲醇,2,3,4,5,6-五氟-a-[(苯基硫代)甲基]-,(R)- 苯甲酸,3-[[2-[(二甲氨基)甲基]苯基]硫代]-,盐酸 苯甲胺,5-氟-2-((3-甲氧苯基)硫代)-N,N-二甲基-,盐酸 苯甲二硫酸,4-溴苯基酯